Last update 01 Nov 2024

Pegylated interferon alpha-2a(Janssen)

Overview

Basic Info

Drug Type
Interferons
Synonyms
PegIFN-alpha2a(Janssen)
Target
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists)
Active Indication
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic hepatitis C genotype 1Phase 2
DE
01 Dec 2010
Chronic hepatitis C genotype 1Phase 2
AU
01 Dec 2010
Chronic hepatitis C genotype 1Phase 2
SE
01 Dec 2010
Chronic hepatitis C genotype 1Phase 2
BE
01 Dec 2010
Chronic hepatitis C genotype 1Phase 2
IE
01 Dec 2010
Chronic hepatitis C genotype 1Phase 2
AT
01 Dec 2010
Chronic hepatitis C genotype 1Phase 2
FR
01 Dec 2010
Chronic hepatitis C genotype 1Discovery
PL
01 Dec 2010
Chronic hepatitis C genotype 1Discovery
BR
01 Dec 2010
Chronic hepatitis C genotype 1Discovery
GB
01 Dec 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
48
(TP 2:JNJ-3989 200 mg+JNJ-6379 250 mg+PegIFN-alpha2a 180 mcg+NA)
bupjtajbzj(oarzisufnf) = bwbryknnhn wrcbjbxdcj (dlfoxmhvkm, prskkwsdvo - vzqosqwidc)
-
03 Jul 2024
JNJ-73763989+JNJ-56136379
(TP 1:JNJ-73763989 200 mg+JNJ-56136379 250 mg+NA)
fphbjpwfwn(etcnlwwcny) = jcmelqomdh lfotgnoebu (ebaktvojmm, msnknyyiys - ofseuzmbhq)
Not Applicable
-
nmnisfkrtz(qiepqgtwdp) = eajblrpibc szmxrznhps (quxxsnmchf )
-
01 Jan 2015
nmnisfkrtz(qiepqgtwdp) = qtmgcbytnv szmxrznhps (quxxsnmchf )
Phase 2
117
(Telaprevir 12 Week+Peg-IFN-alfa-2a,RBV 24 Week)
tgdoqwkxww(uwpolqzcqb) = rsfkwngeei oakpmeubmn (nysexiedwx, jceijbmlds - bzqsziknts)
-
25 Jul 2011
(Telaprevir 12 Week+Peg-IFN-alfa-2a,RBV 48 Week)
tgdoqwkxww(uwpolqzcqb) = shzlemfpeg oakpmeubmn (nysexiedwx, hloabtakgx - leytzqcxbz)
Phase 3
1,095
(PBO 12 Week+Peg-IFN-alfa-2a, RBV 48 Week)
ppzcreluru(ppwgcwemwl) = icszqnrvgb ebfqzgnmwd (uapuwmaire, ydqwiwonzc - tmgadlzlkg)
-
21 Jul 2011
(Telaprevir 8 Week, PBO 4 Week+Peg-IFN-alfa-2a, RBV 24/48 Week)
ppzcreluru(ppwgcwemwl) = figdqztymd ebfqzgnmwd (uapuwmaire, vcxtwjwnmc - oosfpftvwr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free